Purchase Order 36C24221P0312
- Not listed
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The one-year, $808,537.12 delivery order contract is for Firm Fixed Price infectious disease testing products and services, including molecular diagnostic testing, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, a $126,652.50 firm-fixed-price purchase order for BioFire RP2.1 panel reagents. The contract has a completion date of February 15, 2022 and was awarded on December 3, 2020. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts from agencies such as the VA, Defense Health Agency,...
- The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, to provide COVID-19 testing kits. The $230,850 contract has a period of performance from July 2020 to July 2021 and is not associated with a set-aside program. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts to provide diagnostic testing services,...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotech company that specializes in syndromic infectious disease testing. The contract, valued at $3,679,381.66, is for the provision of reagents on a cost-per-test basis. The contract was awarded on March 23, 2017, with a completion date of August 16, 2022, and is associated with the Coronavirus COVID-19 national interest...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization that specializes in syndromic infectious disease testing. The $125,500.00 firm-fixed-price purchase order does not have a set-aside designation. Biofire Diagnostics LLC has received numerous federal contracts as a prime contractor to provide a variety of goods and services related to infectious disease...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in infectious disease testing. The $110,160.00 firm-fixed-price purchase order was issued under the VA VISN 9 network for COVID-19 panel testing using Biofire's 423738 COVID emergency testing products. No set-aside was used. Biofire Diagnostics has held numerous federal contracts with the VA,...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide BIOFIRE REAGENTS FOR TESTING COVID-19. The $438,741.54 firm-fixed-price order was placed against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. No set-aside was used. Biofire is a leader in syndromic infectious disease...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract is a Blanket Purchase Agreement (BPA) call order under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a potential value of $297,026.26 and a...
- This contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company, is for the provision of COVID-19 testing kits to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 10. The $107,730.00 firm-fixed-price purchase order was issued on October 1, 2020, with a completion date of September 30, 2021. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The $153,253.50 firm fixed-price delivery order is for reagents under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for In-Vitro Diagnostics, Reagents, and Tests. The contract is part of a larger Indefinite Delivery Contract (IDC) issued by VHA's Veterans Integrated...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide COVID-19 testing reagents. The $223,560 firm fixed-price purchase order has a completion date of September 30, 2021. Biofire Diagnostics LLC has received numerous federal contracts to supply infectious disease testing products and services, including molecular diagnostic testing, reagents, and maintenance for their equipment. The award was not set aside for any specific business type. Biofire Diagnostics LLC holds several indefinite delivery contracts and blanket purchase agreements with the VA and other agencies like the Indian Health Service to facilitate ongoing procurement of their diagnostic testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 7/30/21 | |
| Not listed | Not listed | $223.6k | 12/22/20 |